日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors

一项针对晚期实体瘤的双硫仑、铜和长春瑞滨的安全性和有效性的 1b 期开放标签、剂量递增研究

Eefsen, Rikke Løvendahl; Stenvang, Jan; Bartek, Jiri; Pfeiffer, Per; Tarpgaard, Line; Theile, Susann; Brünner, Nils; Nielsen, Dorte L

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel.

吉西他滨和白蛋白紫杉醇治疗不可切除胰腺癌患者肿瘤中 ABCG2 蛋白的表达

Shim Susy, Nielsen Mette Bak, Eld Mikkel, Stenvang Jan, Brøndum Rasmus Froberg, Weber Britta, Motavaf Anne Krejbjerg, Ladekarl Morten

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer

PANTAX:一项针对不可切除或转移性胰腺癌的Ib期临床试验,研究外排泵抑制剂SCO-101联合吉西他滨和白蛋白紫杉醇的疗效。

Shim, Susy; Reinacher-Schick, Anke; Kraeft, Anna-Lena; Per Pfeiffer; Tarpgaard, Line Schmidt; Ettrich, Thomas Jens; Kestler, Angelika; Christensen, Signe; Jandu, Haatisha; Nawabi, Mubeen; Roest, Nicklas Lindland; Damstrup, Lars; Vestlev, Peter Michael; Brünner, Nils; Stenvang, Jan; Ladekarl, Morten

Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer

靶向滋养层细胞表面抗原2 (Trop-2) 的抗体药物偶联物 (ADC) 和乳腺癌的精准治疗

Stenvang, Jan; Vestlev, Peter Michael; Jensen, Benny Vittrup; Pfeiffer, Per

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

一项全面的 RNA 研究旨在识别乳腺癌多西他赛耐药性的 circRNA 和 miRNA 生物标志物

Huang Peide, Li Fengyu, Mo Zongchao, Geng Chunyu, Wen Fang, Zhang Chunyan, Guo Jia, Wu Song, Li Lin, Brünner Nils, Stenvang Jan

Four phase 1 trials to evaluate the safety and pharmacokinetic profile of single and repeated dosing of SCO-101 in adult male and female volunteers

四项 1 期试验旨在评估 SCO-101 在成年男性和女性志愿者中单次和重复给药的安全性和药代动力学特征。

Bergmann, Troels K; Stage, Tore B; Stenvang, Jan; Christophersen, Palle; Jacobsen, Thomas A; Roest, Nicklas L; Vestlev, Peter M; Brünner, Nils

BMP-2 induces EMT and breast cancer stemness through Rb and CD44.

BMP-2 通过 Rb 和 CD44 诱导 EMT 和乳腺癌干细胞特性

Huang Peide, Chen Anan, He Weiyi, Li Zhen, Zhang Guanglin, Liu Zhong, Liu Ge, Liu Xueting, He Shuilian, Xiao Gang, Huang Feicheng, Stenvang Jan, Brünner Nils, Hong An, Wang Ju

Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review

ABCG2表达对伊立替康治疗结直肠癌患者的影响:综述

Nielsen, Dorte Lisbet; Palshof, Jesper Andreas; Brünner, Nils; Stenvang, Jan; Viuff, Birgitte Martine

The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

乳腺癌细胞获得多西他赛耐药性过程中外显子的逐步演变

Hansen, Stine Ninel; Ehlers, Natasja Spring; Zhu, Shida; Thomsen, Mathilde Borg Houlberg; Nielsen, Rikke Linnemann; Liu, Dongbing; Wang, Guangbiao; Hou, Yong; Zhang, Xiuqing; Xu, Xun; Bolund, Lars; Yang, Huanming; Wang, Jun; Moreira, Jose; Ditzel, Henrik J; Brünner, Nils; Schrohl, Anne-Sofie; Stenvang, Jan; Gupta, Ramneek

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification

一项针对奥沙利铂耐药且伴有TOP2A基因扩增的转移性结直肠癌患者的II期临床研究,评估表柔比星的疗效

Tarpgaard, Line S; Qvortrup, Camilla; Nygård, Sune B; Nielsen, Signe L; Andersen, Diana R; Jensen, Niels Frank; Stenvang, Jan; Detlefsen, Sönke; Brünner, Nils; Pfeiffer, Per